AUTHOR=Hu Xuemei , Zhao Mingyang , Yang Xue , Wang Dongsen , Wu Qingjian TITLE=Association between the SLC6A11 rs2304725 and GABRG2 rs211037 polymorphisms and drug-resistant epilepsy: a meta-analysis JOURNAL=Frontiers in Physiology VOLUME=Volume 14 - 2023 YEAR=2023 URL=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2023.1191927 DOI=10.3389/fphys.2023.1191927 ISSN=1664-042X ABSTRACT=Background: Previous studies have shown that SLC6A11 and GABRG2 are linked to drug-resistant epilepsy (DRE), although there have been conflicting results in the literature. Here, we systematically assessed the relationship between DRE and these two genes. Methods: We systematically searched the PubMed, Embase, Cochrane Library, Web of Science, Wan-fang Data, CNKI and VIP databases. To clarify whether heterogeneity existed between studies, tools such as the Q test and I2 statistic were selected. According to study heterogeneity, we chose fixed- or random-effects models for analysis. We then used the chi-squared ratio to evaluate any bias of the experimental data. Results:In the allele models, SLC6A11 rs2304725 and GABRG2 rs211037 had no significant correlation with DRE risk. To further investigate the relationship with DRE, we performed model tests on the two genes separately. We identified that rs2304725 was only weakly related to DRE for the three models (additive model: OR = 0.91, 95% CI: 0.73–1.13, P = 0.38; recessive model: OR = 0.99, 95% CI: 0.83–1.17, P = 0.89; dominant model: OR = 0.89, 95% CI: 0.74–1.08, P = 0.25) in a pooled population. For the over-dominant model, DRE was correlated with rs2304725(OR = 1.08, 95% CI: 0.92–1.27, P = 0.33) in a pooled population. Similarly, rs211037 was weakly significantly correlated with DRE for the dominant model (OR = 0.95, 95% CI: 0.65–1.40, P = 0.04), recessive model (OR = 0.65, 95% CI: 0.37–1.16, P = 0.01), over-dominant model (OR = 0.86, 95% CI: 0.69–1.08, P = 0.55), and additive model (OR = 0.50, 95% CI: 0.13–1.89, P = 0.08) in a pooled population. The subgroup analysis results showed that rs211037 expressed a genetic risk of DRE in a dominant model (OR = 1.11, P = 0.73) and an additive model (OR = 1.10, P = 0.76) in an Asian population. Conclusion: In this meta-analysis, our results show that SLC6A11 rs2304725 and GABRG2 rs211037 are not significantly correlated with DRE. However, in the over-dominant model, rs2304725 was significantly correlated with DRE. Likewise, rs211037 conveyed genetic risk for DRE in an Asian population in both the dominant model and additive models.